Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study.

Osborne LM, Gispen F, Sanyal A, Yenokyan G, Meilman S, Payne JL.

Psychoneuroendocrinology. 2017 May;79:116-121. doi: 10.1016/j.psyneuen.2017.02.012. Epub 2017 Feb 16.

PMID:
28278440
3.

Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Eisenlohr-Moul TA, DeWall CN, Girdler SS, Segerstrom SC.

Biol Psychol. 2015 Jul;109:37-52. doi: 10.1016/j.biopsycho.2015.03.016. Epub 2015 Mar 30.

4.

Increased childhood abuse in patients with premenstrual dysphoric disorder in a Turkish sample: a cross-sectional study.

Soydas EA, Albayrak Y, Sahin B.

Prim Care Companion CNS Disord. 2014 Jul 24;16(4). doi: 10.4088/PCC.14m01647. eCollection 2014.

5.

Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective.

Sundström Poromaa I, Gingnell M.

Front Neurosci. 2014 Nov 24;8:380. doi: 10.3389/fnins.2014.00380. eCollection 2014. Review.

6.

Allopregnanolone as a mediator of affective switching in reproductive mood disorders.

Schiller CE, Schmidt PJ, Rubinow DR.

Psychopharmacology (Berl). 2014 Sep;231(17):3557-67. doi: 10.1007/s00213-014-3599-x. Epub 2014 May 21. Review.

7.

GABAergic neuroactive steroids: a new frontier in bipolar disorders?

Carta MG, Bhat KM, Preti A.

Behav Brain Funct. 2012 Dec 19;8:61. doi: 10.1186/1744-9081-8-61. Review.

8.

Neurosteroids and GABA-A Receptor Function.

Wang M.

Front Endocrinol (Lausanne). 2011 Oct 4;2:44. doi: 10.3389/fendo.2011.00044. eCollection 2011.

9.

Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.

Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED.

Biol Psychiatry. 2011 Feb 15;69(4):374-80. doi: 10.1016/j.biopsych.2010.09.029. Epub 2010 Nov 18.

10.

The GABAergic deficit hypothesis of major depressive disorder.

Luscher B, Shen Q, Sahir N.

Mol Psychiatry. 2011 Apr;16(4):383-406. doi: 10.1038/mp.2010.120. Epub 2010 Nov 16.

12.

Tolerance to allopregnanolone with focus on the GABA-A receptor.

Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson IM.

Br J Pharmacol. 2011 Jan;162(2):311-27. doi: 10.1111/j.1476-5381.2010.01059.x. Review.

13.

Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats.

Pazol K, Northcutt KV, Patisaul HB, Wallen K, Wilson ME.

Physiol Behav. 2009 Apr 20;97(1):58-61. doi: 10.1016/j.physbeh.2009.01.021. Epub 2009 Feb 7.

14.

Update on research and treatment of premenstrual dysphoric disorder.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E.

Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Review.

15.

Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective.

Martel MM, Klump K, Nigg JT, Breedlove SM, Sisk CL.

Horm Behav. 2009 Apr;55(4):465-79. doi: 10.1016/j.yhbeh.2009.02.004. Epub 2009 Mar 2. Review.

16.

Sex steroid-related candidate genes in psychiatric disorders.

Westberg L, Eriksson E.

J Psychiatry Neurosci. 2008 Jul;33(4):319-30. Review.

17.

Premenstrual dysphoric disorder: burden of illness and treatment update.

Pearlstein T, Steiner M.

J Psychiatry Neurosci. 2008 Jul;33(4):291-301.

18.

Premenstrual syndrome.

Yonkers KA, O'Brien PM, Eriksson E.

Lancet. 2008 Apr 5;371(9619):1200-10. doi: 10.1016/S0140-6736(08)60527-9.

19.

Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome.

Baker FC, Kahan TL, Trinder J, Colrain IM.

Sleep. 2007 Oct;30(10):1283-91.

20.

Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.

Mody I.

Neurochem Int. 2008 Jan;52(1-2):60-4. Epub 2007 Jul 17. Review.

Supplemental Content

Support Center